Researchers want to find out if giving the drug Apremilast in combination with Clobetasol spray can help people clear their moderate to severe plaque psoriasis quicker than if Apremilast is used by itself.
|Condition or disease||Intervention/treatment||Phase|
|Psoriasis||Combination Product: Apremilast and Clobetasol||Phase 4|
People over age 18 with moderate to severe plaque psoriasis who choose to be in the study and pass the four week screening period will visit the study center about 8 times over about 16 weeks. All participants will be given Apremilast, a pill that you take in the morning and at night, and which studies have shown may reduce inflammation and improve psoriasis symptoms. All participants will also be given Clobetasol to spray twice daily for two weeks, then once daily for two weeks, then every other day for two weeks. All drugs and study visits are at no cost to participants.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis|
|Actual Study Start Date :||February 25, 2018|
|Estimated Primary Completion Date :||March 1, 2020|
|Estimated Study Completion Date :||June 30, 2020|